Old Web
English
Sign In
Acemap
>
authorDetail
>
Hans Wildiers
Hans Wildiers
Université catholique de Louvain
Medicine
Oncology
Internal medicine
Taxane
Paclitaxel
3
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer
2019
Breast Cancer Research and Treatment
Vandana G. Abramson
Mafalda Oliveira
Andrés Cervantes
Hans Wildiers
Manish R. Patel
Todd Michael Bauer
Philippe L. Bedard
Carlos Becerra
Stephen Lane Richey
Michael C. Wei
Eric Reyner
John Bond
Na Cui
Timothy R. Wilson
Heather M. Moore
Cristina Saura
Ian E. Krop
Show All
Source
Cite
Save
Citations (1)
Risk-reducing mastectomy in BRCA carriers: survival is not the issue
2019
Breast Cancer Research and Treatment
P Neven
Kevin Punie
Hans Wildiers
N. Willers
C. Van Ongeval
G. Van Buggenhout
E. Legius
Show All
Source
Cite
Save
Citations (3)
Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)
2019
Breast Cancer Research and Treatment
Christel Fontaine
Vincent Renard
Heidi Van den Bulk
Peter Vuylsteke
Philip Glorieux
C. Dopchie
Lore Decoster
Leen Vanacker
Evandro de Azambuja
Jacques De Grève
Ahmad Awada
Hans Wildiers
Show All
Source
Cite
Save
Citations (1)
1